Qin J, Jin M H, Deng J H
Affiliated First Hospital, Sun Yat-Sen University of Medical Sciences, Guangzhou.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Sep;17(9):519-22.
To elucidate the relationship between Dampness and blood stasis in patients with coronary heart disease (CHD).
One hundred and twenty-eight CHD patients with Phlegm-Dampness Syndrome (PDS) and 69 with blood stasis syndrome (BSS) were chosen and treated by eliminating Dampness and removing blood stasis.
(1) CHD-PDS and -BSS possessed the similar changes on hemorheology, oxygen free radical, blood lipids and vascular active substance. (2) Both of these two methods could alleviate angina (effective rate was 88.3%, 89.9%), improve ischemic S-T segment changes in ECG obviously and reduce consumption of nitroglycerin significantly (P < 0.01), improve abnormal hemorheology obviously (P < 0.001), raise PGI2, SOD obviously (P < 0.01) and lowered TXA2, MDA, ANP, ET and blood lipids significantly (P < 0.001). (3) The two methods could regulate imbalanced state of PGI2/TXA2,SOD/MDA.
CHD-PDS and -BSS had similar pathologic basis or pathologic changes, could eliminate the Dampness also had possessed similar pharmacologic or pharmacodynamic action of removing blood stasis. According to this, the viewpoint of "blood stasis due to Dampness" might be proved from clinical aspect.
阐明冠心病(CHD)患者中湿与血瘀的关系。
选取128例痰浊证冠心病患者和69例血瘀证患者,采用祛湿化瘀法进行治疗。
(1)冠心病痰浊证和血瘀证在血液流变学、氧自由基、血脂及血管活性物质方面具有相似变化。(2)两种方法均能缓解心绞痛(有效率分别为88.3%、89.9%),明显改善心电图缺血性S-T段改变,显著减少硝酸甘油用量(P<0.01),明显改善异常血液流变学(P<0.001),显著升高前列环素(PGI2)、超氧化物歧化酶(SOD)(P<0.01),并显著降低血栓素A2(TXA2)、丙二醛(MDA)、心钠素(ANP)、内皮素(ET)及血脂(P<0.001)。(3)两种方法均可调节PGI2/TXA2、SOD/MDA的失衡状态。
冠心病痰浊证和血瘀证具有相似的病理基础或病理变化,祛湿化瘀具有相似的药理或药效作用。据此,“湿瘀互结”的观点可能从临床角度得到证实。